Long-term survival rates of patients with stage IIIB and IV non-small cell lung cancer treated with cisplatin plus vinorelbine or gemcitabine.

Long-term survival rates of patients with stage IIIB and IV non-small cell lung cancer treated with cisplatin plus vinorelbine or gemcitabine.

Item
http://www.wikidata.org/entity/Q36386649
WEE1 kinase polymorphism as a predictive biomarker for efficacy of platinum-gemcitabine doublet chemotherapy in advanced non-small cell lung cancer patients.Is there a subgroup of long-term evolution among patients with advanced lung cancer?: hints from the analysis of survival curves from cancer registry data.Indirect comparison of the efficacy and safety of gefitinib and cetuximab-based therapy in patients with advanced non-small-cell lung cancer.Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1α destabilizationImpact of ABCG2 polymorphisms on the clinical outcome of TKIs therapy in Chinese advanced non-small-cell lung cancer patientsObservation of hepatotoxicity during long-term gefitinib administration in patients with non-small-cell lung cancer.Five-Year Survival in EGFR-Mutant Metastatic Lung Adenocarcinoma Treated with EGFR-TKIs.Durable complete remission of poor performance status metastatic lung adenocarcinoma patient treated with second-line erlotinib: a case report.Mitochondrial pathway-mediated apoptosis is associated with erlotinib-induced cytotoxicity in hepatic cells.Factors associated with the prognosis and long-term survival of patients with metastatic lung adenocarcinoma: a retrospective analysis.[Drug induced hepatotoxicity in targeted therapy for lung cancer].
P2860

Long-term survival rates of patients with stage IIIB and IV non-small cell lung cancer treated with cisplatin plus vinorelbine or gemcitabine.

Item
http://www.wikidata.org/entity/Q36386649
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Long-term survival rates of pa ...... us vinorelbine or gemcitabine.
@ast
Long-term survival rates of pa ...... us vinorelbine or gemcitabine.
@en
type
label
Long-term survival rates of pa ...... us vinorelbine or gemcitabine.
@ast
Long-term survival rates of pa ...... us vinorelbine or gemcitabine.
@en
prefLabel
Long-term survival rates of pa ...... us vinorelbine or gemcitabine.
@ast
Long-term survival rates of pa ...... us vinorelbine or gemcitabine.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Long-term survival rates of pa ...... lus vinorelbine or gemcitabine
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932